Prestige Consumer Healthcare Inc. (PBH)
NYSE·Healthcare·Medical - Distribution
$58.62
+0.55%
Mkt Cap $2.77B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 5, 2026 | $282.21M | $283.44M | +0.44% | $1.16 | $1.14 | -1.72% | — | — |
| Q4 2025 Nov 6, 2025 | $294.15M | $274.11M | -6.81% | $0.97 | $1.07 | +10.31% | — | — |
| Q3 2025 Aug 7, 2025 | $275.00M | $249.53M | -9.26% | $1.01 | $0.95 | -5.94% | — | — |
| Q2 2025 May 8, 2025 | $270.41M | $296.75M | +9.74% | $1.30 | $1.32 | +1.54% | — | — |
| Q1 2025 Feb 6, 2025 | $289.81M | $290.32M | +0.18% | $1.16 | $1.22 | +5.17% | — | — |
| Q4 2024 Nov 7, 2024 | $282.09M | $283.55M | +0.52% | $1.08 | $1.09 | +0.93% | — | — |
| Q3 2024 Aug 8, 2024 | $260.53M | $267.14M | +2.54% | $0.86 | $0.90 | +4.65% | — | — |
| Q2 2024 May 14, 2024 | $287.42M | $276.99M | -3.63% | $1.14 | $0.98 | -14.04% | — | — |
| Q1 2024 Feb 8, 2024 | $280.25M | $282.74M | +0.89% | $1.04 | $1.06 | +1.92% | — | — |
| Q4 2023 Nov 2, 2023 | $285.22M | $286.32M | +0.39% | $1.07 | $1.07 | +0.00% | — | — |
| Q3 2023 Aug 3, 2023 | $278.62M | $279.31M | +0.25% | $1.01 | $1.06 | +4.95% | — | — |
| Q2 2023 May 4, 2023 | $279.00M | $285.87M | +2.46% | $1.04 | $1.07 | +2.88% | — | — |
| Q1 2023 Feb 2, 2023 | $273.84M | $275.52M | +0.62% | $1.01 | $1.04 | +2.97% | — | — |
| Q4 2022 Nov 3, 2022 | $283.20M | $289.27M | +2.14% | $1.00 | $1.02 | +2.00% | — | — |
| Q3 2022 Aug 4, 2022 | $268.92M | $277.06M | +3.02% | $1.04 | $1.09 | +4.81% | — | — |
| Q2 2022 May 5, 2022 | $258.25M | $266.94M | +3.36% | $0.89 | $0.91 | +2.25% | — | — |
| Q1 2022 Feb 3, 2022 | $258.73M | $274.47M | +6.08% | $0.88 | $0.99 | +12.50% | — | — |
| Q4 2021 Nov 4, 2021 | $261.19M | $276.23M | +5.76% | $0.99 | $1.02 | +3.03% | — | — |
| Q3 2021 Aug 5, 2021 | $269.18M | $269.18M | +0.00% | $0.87 | $1.14 | +31.03% | — | — |
| Q2 2021 May 6, 2021 | $229.50M | $237.76M | +3.60% | $0.78 | $0.79 | +1.28% | — | — |